Losartan and magnesium sulfate administration reduce gentamicin-induced nephrotoxicity in rat model
Journal of Nephropathology · 20.08.2018 · 8 (2) · 16-16
DOI: 10.15171/jnp.2019.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nephropathology, online erschienen am 20.08.2018. Verfasst von Fatemeh Kourkinejad Gharaei und 3 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Nephrotoxicity is the most known side effect of gentamicin. In addition, renin angiotensin system (RAS) plays an important role in the pathogenesis of renal injury and nephrotoxicity. Hypomagnesaemia is other complication of gentamicin. Previous studies reported that magnesium plays an important role in cell enzymatic functions, reducing lipid peroxidation.
Objectives
We investigated the role of losartan and magnesium sulfate (MgSO4 ) on gentamicin nephrotoxicity. Materials and Methods: In this study, rats randomly assigned to five groups. The first group, received saline, the second group received gentamicin 80 mg/kg/d, intraperitoneally (ip), and the third group, received a regular dose of losartan, 10 mg/kg/d + gentamicin 80 mg/kg/d. The fourth group received MgSO4 , 80 mg/kg/d + gentamicin 80 mg/kg/d. The fifth group obtained a continuous dose of gentamicin 80 mg/kg/d + losartan 10 mg/kg/d + MgSO4 80 mg/kg/d simultaneously. Nine days after administration of drugs, blood samples were collected from the heart. The level of urea, creatinine (Cr), malondialdehyde (MDA) and nitrite were measured in the animal serum and homogenized kidney tissue.
Results
Gentamicin increased serum urea and Cr levels. The administration of losartan and MgSO4 lonely and combination of them, significantly reduced the levels of serum urea and Cr. Losartan alone and combination of losartan and MgSO4 compared with gentamicin, significantly decreased kidney MDA level too. Decrease of kidney nitrite level by gentamicin was compensated by the administration of losartan, MgSO4 alone or their combination. Additionally, losartan and MgSO4 alone and their combination together significantly reduced renal damage.
Conclusions
The results of this study indicated that administration of losartan and MgSO4 individually and their combination decreased kidney nephrotoxicity and improved renal function. This effect is probably related to the improvement of antioxidant status and renal blood flow.
Zitieren
APA
Gharaei, F. K., Safari, T., Niazi, A. A., & Bujani, M. Z. (2018). Losartan and magnesium sulfate administration reduce gentamicin-induced nephrotoxicity in rat model. Journal of Nephropathology, 8(2), 16-16. https://doi.org/10.15171/jnp.2019.16
Vancouver
Gharaei FK, Safari T, Niazi AA, Bujani MZ. Losartan and magnesium sulfate administration reduce gentamicin-induced nephrotoxicity in rat model. Journal of Nephropathology. 2018;8(2):16-16. doi:10.15171/jnp.2019.16
BibTeX
@article{Gharaei2018,
author = {Gharaei, Fatemeh Kourkinejad and Safari, Tahereh and Niazi, Abbass Ali and Bujani, Meysam Zeynali},
title = {Losartan and magnesium sulfate administration reduce gentamicin-induced nephrotoxicity in rat model},
journal = {Journal of Nephropathology},
year = {2018},
volume = {8},
number = {2},
pages = {16--16},
doi = {10.15171/jnp.2019.16}
}
EUVIMED